More than 50 percent of all the human malignant tumors, for instance liver cancer, breast cancer, bladder cancer, gastric cancer, colon cancer, prostate cancer, soft tissue sarcoma, ovarian cancer, brain tumor, lymphatic tumors, esophageal cancer, lung cancer, osteogenic sarcoma, are the result of a mutation or deletion of the TP53 gene [42–44]. Here, TP53 is linked to cancer.